Tatva Chintan Pharma Chem quarterly results and financials

Tatva Chintan Pharma Chem (TATVA)₹1,668+2.70%(9 Nov 2026 close)Specialty Chemicals

Key facts

In the Sep 2026 quarter (consolidated), Tatva Chintan Pharma Chem reported sales of ₹217 Cr, up 75.1% from Sep 2025, and net profit of ₹21.06 Cr, up 109.8% year on year. For the year to Mar 2026, sales were ₹505 Cr and net profit ₹42.12 Cr.

Sales (Sep 2026): ₹217 Cr
Net profit (Sep 2026): ₹21.06 Cr
Sales (FY Mar 2026): ₹505 Cr
Net profit (FY Mar 2026): ₹42.12 Cr
EPS (Sep 2026): ₹9.18
Borrowings (Mar 2026): ₹120 Cr

Company filings, consolidated accounts; latest reported quarter Sep 2026

Tatva Chintan Pharma Chem quarterly results

₹ crore unless stated; each column is a quarter.

Tatva Chintan Pharma Chem Quarterly results
	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Sales	83.84	97.86	105	82.88	85.92	108	117	124	131	134	167	217
Expenses	73.13	83.20	93.19	78.23	79.25	99.29	100	101	106	106	135	178
Operating Profit	11.04	16.06	13.05	6.02	7.03	9.03	17.07	22.07	25.07	28.11	32.13	41.14
OPM %	13.0%	16.0%	12.0%	7.0%	8.0%	8.0%	15.0%	18.0%	19.0%	21.0%	19.0%	19.1%
Other Income	0.99	4.98	0.99	0.00	0.00	0.99	0.99	0.99	1.99	0.00	0.99	1.99
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.01	0.00	1.01	2.01	3.01
Depreciation	6.97	5.98	6.97	6.98	6.97	6.98	8.97	8.96	8.96	9.96	10.96	10.95
Profit before tax	4.99	14.01	7.01	−0.99	0.00	1.99	9.01	14.01	17.99	17.01	21.01	28.99
Tax %	34.0%	30.0%	24.0%	−34.0%	−165.0%	49.0%	27.0%	27.0%	14.0%	38.0%	24.0%	26.0%
Exceptional items	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	−0.99	0.00
Net Profit	3.01	10.04	5.01	−1.01	0.00	1.01	7.03	10.04	15.04	10.03	16.07	21.06
EPS (Rs)	1.49	4.12	2.24	−0.29	0.07	0.45	2.85	4.25	6.50	4.42	6.84	9.18

Tatva Chintan Pharma Chem profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Tatva Chintan Pharma Chem Profit and loss
	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	136	206	263	299	434	423	393	383	505	648
Expenses	113	172	209	235	326	364	326	349	413	525
Operating Profit	23.07	34.14	55.17	67.21	109	61.22	69.24	35.13	94.38	126
OPM %	17.0%	17.0%	21.0%	22.0%	25.1%	14.0%	17.0%	9.0%	18.0%	19.5%
Other Income	0.99	0.99	0.99	4.98	8.96	1.99	6.97	1.99	2.99	4.97
Interest	3.01	4.01	4.02	4.02	5.02	9.03	7.02	2.01	3.01	6.03
Depreciation	2.99	3.99	4.98	6.97	7.97	9.96	25.89	27.90	36.87	40.83
Profit before tax	18.99	26.99	47.99	61.04	104	45.01	44.02	7.99	57.01	85.00
Tax %	35.0%	25.0%	21.0%	14.0%	8.0%	−2.0%	30.0%	25.0%	26.0%	—
Exceptional items	0.00	0.99	0.00	0.00	0.00	−2.99	0.00	0.00	0.00	−0.99
Net Profit	12.05	21.07	38.11	52.20	96.35	45.13	30.12	6.02	42.12	62.20
EPS (Rs)	6.12	10.24	18.81	26.06	43.26	20.54	12.98	2.45	17.99	26.94
Dividend payout %	0.0%	0.0%	0.0%	19.0%	5.0%	10.0%	15.0%	41.0%	11.0%	—

Tatva Chintan Pharma Chem balance sheet

₹ crore, at each year end.

Tatva Chintan Pharma Chem Balance sheet
	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	7.97	7.97	7.97	19.93	21.94	21.97	22.99	23.01	23.00
Reserves	50.80	71.75	110	145	449	492	714	715	757
Borrowings	56.15	77.15	91.20	90.29	120	171	14.06	36.14	120
Other Liabilities	28.00	31.05	40.98	59.12	65.29	74.35	67.32	61.29	102
Total Liabilities	144	188	249	315	657	759	819	837	1,004
Fixed Assets	57.11	67.15	111	120	160	196	428	530	611
CWIP	10.02	6.01	5.01	10.02	51.12	231	77.18	24.05	25.08
Investments	0.99	0.00	0.00	0.00	0.00	0.00	10.01	0.00	3.99
Other Assets	75.80	115	133	185	446	331	304	282	364
Inventories	29.02	35.99	64.02	72.03	170	162	153	134	196
Trade receivables	28.96	40.94	49.97	90.86	56.90	83.97	69.95	89.85	119
Cash & equivalents	7.98	15.97	10.98	4.99	177	44.91	37.92	13.96	8.98
Total Assets	144	188	249	315	657	759	819	837	1,004

Tatva Chintan Pharma Chem cash flow

₹ crore, for each year.

Tatva Chintan Pharma Chem Cash flow
	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	12.99	7.01	25.02	20.01	20.01	28.02	97.98	24.99	31.03
Cash from investing activity	−29.97	−16.98	−39.94	−20.96	−197	−101	−121	−64.85	−116
Cash from financing activity	7.01	17.01	10.02	−5.01	235	38.07	31.03	17.03	79.10
Net cash flow	−9.99	8.01	−4.99	−5.99	58.93	−36.01	7.99	−24.01	−5.99
Capex	30.05	10.02	48.05	21.04	89.05	203	129	76.08	114
Free cash flow	−17.99	−1.99	−22.99	−0.99	−68.91	−175	−29.97	−50.99	−81.98
CFO / OP %	105.0%	38.9%	61.0%	44.0%	36.0%	61.0%	157.0%	84.9%	42.0%

Tatva Chintan Pharma Chem ratios

Working-capital days and returns, by year.

Tatva Chintan Pharma Chem Ratios
	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	77	73	69	110	48	73	65	85	86
Inventory days	148	114	175	173	319	262	320	246	319
Days payable	128	72	88	115	84	53	95	61	96
Cash conversion cycle	99	116	157	169	283	283	291	271	310
Working capital days	14	45	46	73	73	24	157	147	91
ROCE %	—	22.0%	28.0%	28.1%	26.0%	9.1%	7.0%	1.0%	7.0%

Tatva Chintan Pharma Chem: frequently asked questions

What are the latest quarterly results of Tatva Chintan Pharma Chem?

For the Sep 2026 quarter, Tatva Chintan Pharma Chem reported sales of ₹217 Cr, up 75.1% year on year and net profit of ₹21.06 Cr, up 109.8% year on year. The operating margin was 19.1%.

What is the annual revenue of Tatva Chintan Pharma Chem?

Tatva Chintan Pharma Chem's sales for the year to Mar 2026 were ₹505 Cr; over the last twelve months they were ₹648 Cr.

What is the net profit of Tatva Chintan Pharma Chem?

Net profit for the year to Mar 2026 was ₹42.12 Cr, and ₹62.20 Cr over the last twelve months. Earnings per share over the same trailing period were ₹26.94.

How much debt does Tatva Chintan Pharma Chem have?

Tatva Chintan Pharma Chem reported borrowings of ₹120 Cr at Mar 2026, against cash and equivalents of ₹8.98 Cr.

What is the free cash flow of Tatva Chintan Pharma Chem?

Cash from operations was ₹31.03 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹81.98 Cr.

Loading…